*Plasmodium malariae* is an uncommonly reported infection in India.\[[@ref1]\] It differs from other species causing malaria, in that it causes quartan fever and has important diagnostic and clinical implications.

We present a case of *P. malariae*, who was infected in Kenya and was diagnosed after coming to India.

A 40-year-old businessman, originally a resident of Calicut, Kerala, and settled in Mombasa, Kenya for the past 20 years, presented with intermittent spikes of high-grade fever and chills of 3-weeks- duration. He had returned to India 4 days before the admission. Fever spike occurred each 4^th^ day. He was asymptomatic in between the fever spikes except for the malaise and tiredness. There was no history of jaundice. He was initially evaluated by a local practitioner in Calicut and was prescribed oral doxycycline, 3 days before the admission. Rapid malarial antigen test done that time was negative.

On examination, he had a fever (temperature: 104 F), tachycardia (pulse: 114/min), and conjunctival congestion. The systemic examination was within normal limits.

Hemoglobin was 12.1 g/dl, red blood cell count - 4.14 million/mm^3^, packed cell volume - 35.9%, white blood cell count - 4500/mm^3^ with 85% neutrophils and marginally decreased platelet count (131,000/mm^3^). Erythrocyte sedimentation rate was raised (45 mm/1^st^ h). Liver function tests, renal function tests, and urine examination were normal.

As suggested from the history, thick and thin smears for malarial parasite were sent. Initially reported as *Plasmodium vivax*, on review, it was confirmed to be *P. malariae* with smear showing characteristic band forms \[[Figure 1](#F1){ref-type="fig"}\].
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Although the rapid diagnostic test for Plasmodium falciparum was negative he was treated with artesunate +sulfadoxine-pyrimethamine for 3 days as coinfection with *Plasmodium falciparum* is common in Africa.\[[@ref2]\] A single dose of primaquine 45 mg was also given. He was discharged in a stable condition after 5 days of in hospital management.

*P. malariae* is relatively common in Kenya.\[[@ref3]\] In India, though there are possible areas with transmission of *P. malariae*, *P. malariae* infection maybe underreported as early ring forms of *P. malariae* are difficult to differentiate from those of *P. vivax*.\[[@ref1]\]

*P. malariae* is difficult to differentiate from *P. vivax* and *Plasmodium knowlesi* on microscopy. There are few differences as compared to vivax. *P. malariae* infects old erythrocytes, ring form is thicker and stains more intensely, infected erythrocytes are normal or small sized and rarely Ziemann\'s stippling may be seen. However, most unique feature of *P. malariae* is the presence of band forms which are late trophozoites stretching across the erythrocyte. In our case, band forms were noted by the pathologist.

Although *P. malariae* does not produce hepatic hypnozoites, the blood infection may persist for very long duration in untreated cases. The recrudescence maybe seen up to 50 years after the initial infection (in contrast to up to 1--2 years in case of *P. falciparum*). *P. malariae* can infect mosquitoes over a long period which sustains its transmission.\[[@ref4]\]

In conclusion, we wish to stress the importance of accurate diagnosis of this infection, which is likely to be misdiagnosed as *P. vivax* and which may present with pathologically different and irreversible form of nephropathy and can cause recrudescence decades after initial infection. The diagnosis may be missed by standard rapid diagnostic tests as they have very low sensitivity for detecting *P. malariae*, which highlights the importance of skilled technicians and pathologists.\[[@ref5]\] Considering the demographics of migrating population in today\'s world such cases may prove to be of significant public health importance.
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